Reacciones adversas asociadas al tratamiento de la leucemia linfoblástica aguda en población pediátrica mexicana: revisión sistemática
Latin american journal of clinical sciences and medical technology · 17.03.2026 · 8 (1) · 38-49
DOI: 10.34141/ljcs8012358 ↗Kurz gefasst
Fachartikel in der Zeitschrift Latin american journal of clinical sciences and medical technology, erschienen am 17.03.2026. Verfasst von Elizabeth Guadalupe Sánchez-González und 4 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Introduction
Acute lymphoblastic leukemia (ALL) is the most common hematologic malignancy in childhood. Current chemotherapy regimens have substantially increased survival; however, they are associated with a high burden of adverse drug reactions (ADRs), particularly in the pediatric population.
Objective
To critically analyze the patterns, frequencies, and severity of ADRs reported in the treatment of ALL in the Mexican pediatric population. The study aims to identify the most frequent ADRs per drug, variability in incidence according to protocols and regions, and the limitations and gaps within the national pharmacovigilance system. Materials and Methods. A systematic review was conducted following the PRISMA 2020 guidelines. International (PubMed / MEDLINE, Scopus, Cochrane) and regional (SciELO, LILACS) scientific databases were consulted, along with pharmacovigilance databases (VigiBase - WHO, FDA, EMA, COFEPRIS) for studies published between 2010-2024. Inclusion criteria were: Mexican pediatric population (
Zitieren
APA
Sánchez-González, E. G., Pedraza, F. R., García, B. J. L., Larrea, J. A. M., & Hernández-Abad, V. J. (2026). Reacciones adversas asociadas al tratamiento de la leucemia linfoblástica aguda en población pediátrica mexicana: revisión sistemática. Latin american journal of clinical sciences and medical technology, 8(1), 38-49. https://doi.org/10.34141/ljcs8012358
Vancouver
Sánchez-González EG, Pedraza FR, García BJL, Larrea JAM, Hernández-Abad VJ. Reacciones adversas asociadas al tratamiento de la leucemia linfoblástica aguda en población pediátrica mexicana: revisión sistemática. Latin american journal of clinical sciences and medical technology. 2026;8(1):38-49. doi:10.34141/ljcs8012358
BibTeX
@article{SnchezGonzlez2026,
author = {Sánchez-González, Elizabeth Guadalupe and Pedraza, Fernanda Rosales and García, Brian Javier Llaca and Larrea, José Antonio Maza and Hernández-Abad, Vicente Jesús},
title = {Reacciones adversas asociadas al tratamiento de la leucemia linfoblástica aguda en población pediátrica mexicana: revisión sistemática},
journal = {Latin american journal of clinical sciences and medical technology},
year = {2026},
volume = {8},
number = {1},
pages = {38--49},
doi = {10.34141/ljcs8012358}
}
EUVIMED